IgM anti-phosphorylcholine
proteinReduced IgM anti-PC fails to neutralize oxidized phospholipid epitopes on atherogenic lipoproteins, increasing thrombotic risk.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleProtective autoantibody against oxidized lipids; low levels signal increased oxidized-lipid burden and MI risk.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes.International journal of cardiology · 2012 · PMID 22305633 · doi